Mr
Kerry
Rees

Partner & Patent Attorney

London Office

Life sciences

Telephone. +44(0) 207 776 5100
Mobile. +44(0) 788 040 8594
Email. [email protected]

Experience

Kerry’s primary focus is patent drafting, prosecution, opposition and appeals before the European Patent Office but he also has extensive experience in all phases of foreign patent prosecution. He also provides FTO/infringement advice.

He undertakes work in a wide variety of technology areas including pharmaceuticals, biologicals, chemistry and biochemistry, microbiology, cell and molecular biology, immunology and medical devices.

Kerry has a particular interest in food technology, including alt proteins, fermentation, cultured meat and cellular agriculture, food ingredients, food feed and food enzymology, advising a variety of companies at various stages of development on IP strategies to attract funding or IP due diligence in preparing for acquisition, and advising on proactive attacking or defensive strategies in relation to third party IP.

Kerry acts for a wide range of clients including start-ups and investors, research institutions, universities and spin-outs, mid-size companies and international corporations.

Kerry works with private equity and venture capital investors to assess and mitigate IP risks associated with an investment. Kerry particularly enjoys working with investee companies to develop IP strategies which support the business plan and to secure commercially relevant IP whether that be to secure funding or increase growth and market share.

Qualifications

Patent Attorney

Chartered (UK)
European


MBIOCHEM

Molecular and Cellular Biochemistry, University of Oxford

POSTGRADUATE DIPLOMA OR CERTIFICATE

Certificate in Intellectual Property Law, University of London

Publications

Selling a business - Midlands Business Insider

View publication online

IP Magazine: Strategies for extending the life of patents

View publication online

Conferences: 2021

May 18th 2021

IP & data protection for alternative proteins: how to protect your products in the EU

Speaker

Event details

Conferences: 2020

December 2nd 2020

Alternative Dairy Conference 2020

Speaker

Event details

November 20th 2020

Jefferies 2020 London Healthcare Conference

Attended

Event details

September 11th 2020

Stevenage Bioscience Catalyst webinar; Intellectual Property: Are you infringing?

Speaker

Event details

September 2nd 2020

Alt Protein Conference - Transforming the Future of Food

Speaker

Event details

Related News

Event - 21st-22nd September 2022

Medical Technology Ireland 2022

Medical Technology Ireland Conference 2022 will be held on 21-22 September at the Galway Racecource. Medical Technology Ireland is a new high-profile National and International event attracting global suppliers to …

Event details

Artificial intelligence inventions in healthcare – can you patent them in Europe?

Artificial Intelligence (AI) has moved from the realm of science fiction firmly into the mainstream of technological innovation. Trained AI models in some cases are able to perform data analysis …

Read article

Patenting digital mental health

Mental health and behavioural disorders have a profound impact on wellbeing worldwide, with an estimated 13% of the global population suffering from a mental health or substance use disorder [1]. …

Read article

Patenting antibodies in the US and Europe

Is the USPTO now stricter than the EPO on antibody claims? A consideration of recent developments from both sides of the pond. Patent protection for monoclonal antibodies, bispecific antibodies and …

Read article

Patentability of Simulations in Europe

Simulations offer a powerful tool in modern-day engineering. Subjecting designs to initial testing in a simulated environment will, for many designs, reduce costs owing to reduced needs to produce and …

Read article

Blockbuster blood thinning patent revoked

Summary Mr Justice Meade has revoked Bristol Myers Squibb’s (BMS) European patent No. EP1427415 (EP’415) and corresponding supplementary protection certificate (SPC) that relate to the compound Apixaban (ELIQUIS) for lack …

Read article
Event - 10th May 2022

The HGF IP in Healthcare Conference 2022

After a challenging couple of years, we are delighted to invite you to join us for HGF’s eighth annual IP in Healthcare Conference. We will review the latest intellectual property …

Event details
Event - 10th May 2022

HGF UPC events in Germany and Austria 2022

HGF is holding a webinar and an in-person event covering the UPC in Germany and Austria this Spring. The provisional phase of the Unified Patent Court (UPC) is now underway …

Event details

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.